NCT06793072 Adipokines in Polycystic Ovary Syndrome
| NCT ID | NCT06793072 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jagiellonian University |
| Condition | PCOS |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-01-20 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2025-01-20 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to compare the concentrations of leptin, resistin, and omentin-1 in women across three research groups: those with polycystic ovary syndrome without insulin resistance, those with polycystic ovary syndrome with insulin resistance, and women without polycystic ovary syndrome.
Eligibility Criteria
Inclusion Criteria: * Age 18-45 Exclusion Criteria: * previous removal of at least one ovary * treated diabetes of any type * diagnosed and treated metabolic diseases * diagnosed and treated autoimmune diseases * diagnosed and treated autoinflammatory diseases(Edited)Restore original
Contact & Investigator
Kazimierz Pityński, Prof., Ph.D., M.D.
STUDY CHAIR
Jagiellonian University
Frequently Asked Questions
Who can join the NCT06793072 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying PCOS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06793072 currently recruiting?
Yes, NCT06793072 is actively recruiting participants. Contact the research team at iwona.gawron@uj.edu.pl for enrollment information.
Where is the NCT06793072 trial being conducted?
This trial is being conducted at Krakow, Poland.
Who is sponsoring the NCT06793072 clinical trial?
NCT06793072 is sponsored by Jagiellonian University. The principal investigator is Kazimierz Pityński, Prof., Ph.D., M.D. at Jagiellonian University. The trial plans to enroll 300 participants.